ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF OLAPARIB USING RP-HPLC, LC-MS AND UV–VISIBLE SPECTROPHOTOMETRY
International Journal of Drug Delivery Technology · 01.06.2026 · 16 (53s)
DOI: 10.25258/ijddt.16.53s.65 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 01.06.2026. Verfasst von Ganesh S. Nagargoje und 3 weiteren Autor:innen.
Abstract (Originalsprache)
The present study focuses on the development and validation of RP–HPLC, LC–MS, and UV–Visible spectrophotometric methods for the estimation of Olaparib, an anticancer drug used in ovarian and breast cancer therapy. RP–HPLC analysis was performed using a C18 column with optimized chromatographic conditions to obtain sharp and well-resolved peaks. LC–MS was developed for sensitive identification and characterization of Olaparib through mass spectral analysis, while the UV–Visible method was based on determination of λmax in the range of 200–400 nm. All methods were validated according to ICH guidelines for parameters including accuracy, precision, linearity, robustness, specificity, LOD, and LOQ. The developed methods were found to be simple, accurate, precise, sensitive, and suitable for routine quality control analysis of Olaparib in bulk and pharmaceutical dosage forms.
Zitieren
APA
Nagargoje, G. S., Ghotane, R. B., Kole, S. G., & Jadhav, A. (2026). ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF OLAPARIB USING RP-HPLC, LC-MS AND UV–VISIBLE SPECTROPHOTOMETRY. International Journal of Drug Delivery Technology, 16(53s). https://doi.org/10.25258/ijddt.16.53s.65
Vancouver
Nagargoje GS, Ghotane RB, Kole SG, Jadhav A. ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF OLAPARIB USING RP-HPLC, LC-MS AND UV–VISIBLE SPECTROPHOTOMETRY. International Journal of Drug Delivery Technology. 2026;16(53s). doi:10.25258/ijddt.16.53s.65
BibTeX
@article{Nagargoje2026,
author = {Nagargoje, Ganesh S. and Ghotane, Rajanikant B. and Kole, Shruti G. and Jadhav, Avdhut},
title = {ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF OLAPARIB USING RP-HPLC, LC-MS AND UV–VISIBLE SPECTROPHOTOMETRY},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {53s},
doi = {10.25258/ijddt.16.53s.65}
}
EUVIMED